Leonteq Securities’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Leonteq Securities's IOVA Position: Q3 2026 in Review
Leonteq Securities reduced its Iovance Biotherapeutics (IOVA) stake by 60% in Q3 2026, selling an estimated $644K and leaving 60,000 shares worth $889K. The position accounts for 0.04% of the portfolio, ranked #249.
Leonteq Securities first reported a position in IOVA in Q4 2020 and has held it in 23 quarters since. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- Leonteq Securities held 60,000 shares of Iovance Biotherapeutics worth $889K as of Q3 2026.
- Leonteq Securities sold 90,000 Iovance Biotherapeutics shares in Q3 2026, an estimated $644K.
- Iovance Biotherapeutics made up 0.04% of Leonteq Securities's portfolio in Q3 2026, its #249 holding.
- Leonteq Securities first reported a position in Iovance Biotherapeutics in Q4 2020 and has held it in 23 quarters since.
- 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.